Five years after HCA Healthcare took over an esteemed nonprofit hospital in Nort...
The Colombian government has taken a significant step toward issuing a compulsor...
A doctor who treats people with Alzheimer’s doesn't blame Biogen for the Aduhelm...
The Supreme Court is set to hear arguments next month in a case that could have ...
Why @adamfeuerstein believes Novartis is going to walk away from its acquisition...
Vertex’s once-daily cystic fibrosis therapy succeeded in a pair of Phase 3 studi...
Johnson & Johnson faces a consequential new class action lawsuit for allegedly o...
Fatigue is common among long Covid patients, which means that recommendations to...
The case study, about how Krystal Biotech's gene therapy for a rare genetic cond...
The government boiled down its rules about Medicare Advantage plans using AI to ...
Working with the cells of people with peanut allergies, researchers identify a "...
Health Canada has approved Chiesi Global Rare Diseases’ MYALEPTA as a treatment ...
Silence Therapeutics has announced a private placement of its 5,714,286 American...
Incyte has acquired sole worldwide rights to tafasitamab immunotherapy through a...
CB-012 is a gene-modified cell therapy commercialized by Caribou Biosciences, wi...
RT-111 could offer an alternative dosing regimen for patients with psoriasis and...
